申请人:Bae In Hwan
公开号:US20130165386A1
公开(公告)日:2013-06-27
Provided is a pharmaceutical composition comprising, as an active ingredient, a quinoline or quinazoline derivative of formula (I), a pharmaceutically acceptable salt, an isomer, a hydrate, and a solvate thereof, which is effective in the prevention and treatment of a cancer, inflammation, autoimmune diseases or neurodegenerative disorders which are induced by the overexpression of inhibitor of apoptosis proteins (IAPs).
提供的是一种药物组合物,包含一种式子为(I)的喹啉或喹嗪衍生物作为活性成分,以及其药学上可接受的盐、异构体、水合物和溶剂化物。该组合物对于预防和治疗由凋亡抑制蛋白(IAPs)过度表达引起的癌症、炎症、自身免疫性疾病或神经退行性疾病具有有效性。